Skip to main content

Table 5 Genotype/minor-allele frequency distributions of the ACAN, BGN, DCN and VCAN polymorphisms for shoulder disability categories

From: Regulatory VCAN polymorphism is associated with shoulder pain and disability in breast cancer survivors

Gene

SNP

Genotype or allele

No–low

(n = 188)

Moderate–high

(n = 43)

p value

ACAN

rs1126823 A>G

G/G

30 (56)

33 (14)

0.870 (0.987)

A/G

46 (87)

42 (18)

A/A

24 (45)

26 (11)

A

47 (177)

47 (40)

1.000

rs1516797 T>G

G/G

29 (54)

26 (11)

0.864 (0.802)

G/T

45 (84)

44 (19)

T/T

27 (50)

30 (13)

T

49 (184)

52 (45)

0.633

rs2882676 A>C

A/A

31 (58)

29 (12)

0.895 (0.861)

A/C

46 (86)

50 (21)

C/C

23 (43)

21 (9)

C

46 (172)

46 (39)

1.000

BGN

rs1042103 G>A

G/G

73 (137)

72 (31)

0.416 (0.401)

A/G

25 (46)

21 (9)

A/A

3 (5)

7 (3)

A

15 (56)

17 (15)

0.619

rs743641 A>T

A/A

49 (92)

42 (18)

0.431 (0.442)

A/T

42 (78)

42 (18)

T/T

10 (18)

16 (7)

T

30 (114)

37 (32)

0.247

rs743642 G>T

G/G

54 (102)

51 (22)

0.101 (0.101)

G/T

40 (75)

33 (14)

T/T

6 (11)

16 (7)

T

26 (97)

33 (28)

0.226

DCN

rs516115 C>T

T/T

29 (54)

30 (13)

0.976 (0.888)

C/T

52 (97)

51 (22)

C/C

20 (37)

19 (8)

C

46 (171)

44 (38)

0.905

VCAN

rs11726 A>G

G/G

30 (56)

51 (22)

0.024 (0.033)

A/G

53 (99)

33 (14)

A/A

18 (33)

16 (7)

A

44 (165)

33 (28)

0.069

rs2287926 G>A

G/G

67 (125)

54 (23)

0.113 (0.118)

A/G

28 (53)

44 (19)

A/A

5 (10)

2 (1)

A

19 (73)

24 (21)

0.301

rs309559 A>G

G/G

27 (51)

26 (11)

0.662 (0.685)

A/G

49 (92)

44 (19)

A/A

24 (44)

30 (13)

A

48 (180)

52 (45)

0.550

  1. Notes: Genotype and allele frequencies are expressed as a percentage with the number of participants (n) in parentheses. p values in bold typeset indicate significance (p < 0.05), whereas p values in parentheses are adjusted for participants’ age at consent.
  2. Abbreviations: ACAN, Aggrecan; BGN, Biglycan; DCN, Decorin; VCAN, Versican.